Patients who developed PMI (irrespective of IHD history) had a significantly higher mortality rate (8.8% vs. 1.9%, contrast +6.9%, p < 0.001); in the PMI group the proportion of individuals with high inflammatory responses (CRP > 150 mg/L in 69.2% vs. 55.1%, p < 0.001) and LOS > 10 days (61.4% vs. 54.9%, p = 0.013) was also markedly higher. The gene discussed is CRP; the disease is myocardial ischemia.